IDEXX Laboratories’ DCF Stock Analysis

Here’s my assumptions for $IDXX ( ▲ 4.18% ) :

Risk Free Rate (10 Years Interest Rate Swap): 4.09%

Risk Premium (Taken from the Aswath Damodaran equity premium spreadsheet): 4.33%

Interest Rate Spread on The Risk free rate ( For the cost of debt calculation): 3%

Last 24 Moths Beta: 1.06

Historical Data

Revenue growth in the last 10 years (CAGR): 9.30%

Earnings growth in the last 10 years (CAGR): 16.54%

Unlevered Free Cash Flow growth in the last 10 years (CAGR): 16.19%

Future Assumptions

End of Year FCF growth: 10%

Growth until end of 2026: 15%

Growth until end of 2034: 10%

Perpetual growth: 3.1%

Net Debt: 0.895B

Outstanding Stock Options Present Value Assumption: $0.373B

Restricted Stock Units Present Value Assumption: $0.076B

Stock Valuation based on these assumptions: $497

Last update 07/05/2025

All the content in this newsletter should be taken as informational content only. THIS IS NOT FINANCIAL ADVICE! Do your own Due Diligence before investing or contact a professional financial advisor.

I don’t have a position in IDEXX Laboratories (IDXX) and I don’t plan to add a position in the coming days.